Inventor · disambiguated record
Changgeng Qian
Also filed as: QIAN CHANGGENG
55 granted patents·20 pending applications·358 citations·filing 1994–2025
98Inventor score
Top patents by PatentIndex Score
75 records- 0196US8461157B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCAI XIONG·Filed 2011·Granted Jun 11, 2013·27 cites·19 claims
- 0295US8906909B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2013·Granted Dec 9, 2014·17 cites·20 claims
- 0395US8563741B2CDK inhibitors containing a zinc binding moietyQIAN CHANGGENG·Filed 2008·Granted Oct 22, 2013·23 cites·11 claims
- 0495US7547781B2Quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Jun 16, 2009·15 cites·9 claims
- 0594US5750565ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted May 12, 1998·66 cites·29 claims
- 0693US10676482B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2019·Granted Jun 9, 2020·3 cites·4 claims
- 0792US8710219B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCAI XIONG·Filed 2012·Granted Apr 29, 2014·14 cites·8 claims
- 0892US8367663B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2010·Granted Feb 5, 2013·17 cites·25 claims
- 0991US2025230169A1Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding MoietyCURIS INC·Filed 2024·Application pending·0 cites
- 1090US9725461B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2014·Granted Aug 8, 2017·11 cites·18 claims
- 1190US5703093ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Dec 30, 1997·55 cites·22 claims
- 1289US8324240B2Fused amino pyridine as HSP90 inhibitorsCAI XIONG·Filed 2008·Granted Dec 4, 2012·7 cites·14 claims
- 1388US9249156B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2014·Granted Feb 2, 2016·6 cites·9 claims
- 1488US8586605B2Fused amino pyridine as HSP90 inhibitorsCAI XIONG·Filed 2012·Granted Nov 19, 2013·6 cites·25 claims
- 1588US8455506B2Quinazoline based EGFR inhibitors containing a zinc binding moietyQIAN CHANGGENG·Filed 2009·Granted Jun 4, 2013·9 cites·10 claims
- 1688US7977347B2Quinazoline based EGFR inhibitorsCURIS INC·Filed 2007·Granted Jul 12, 2011·11 cites·10 claims
- 1787US8604044B2Quinazoline based EGFR inhibitors containing a zinc binding moietyQIAN CHANGGENG·Filed 2007·Granted Dec 10, 2013·4 cites·12 claims
- 1886US2023192687A1Fused amino pyridine as hsp90 inhibitorsCURIS INC·Filed 2022·Application pending·0 cites
- 1985US2023227467A1Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2023·Application pending·0 cites
- 2084US8119616B2Formulation of quinazoline based EGFR inhibitors containing a zinc binding moietyCAI XIONG·Filed 2008·Granted Feb 21, 2012·3 cites·54 claims
- 2183US11597732B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2022·Granted Mar 7, 2023·0 cites·6 claims
- 2283US8846912B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Sep 30, 2014·2 cites·17 claims
- 2383US8273785B2Substituted 2-indolinone as PTK inhibitors containing a zinc binding moietyCAI XIONG·Filed 2011·Granted Sep 25, 2012·5 cites·8 claims
- 2483US7846938B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2008·Granted Dec 7, 2010·4 cites·25 claims
- 2582US9169244B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Oct 27, 2015·4 cites·10 claims
- 2682US7888361B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Feb 15, 2011·4 cites·9 claims
- 2781US10428068B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2018·Granted Oct 1, 2019·1 cites·2 claims
- 2880US10543197B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2018·Granted Jan 28, 2020·1 cites·6 claims
- 2980US8518910B2Formulation of quinazoline based EGFR inhibitors containing a zinc binding moietyCAI XIONG·Filed 2012·Granted Aug 27, 2013·2 cites·26 claims
- 3079US11654136B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2021·Granted May 23, 2023·0 cites·12 claims
- 3178US7928136B2Substituted 2-indolinone as PTK inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Apr 19, 2011·2 cites·11 claims
- 3277US11560377B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2020·Granted Jan 24, 2023·0 cites·3 claims
- 3377US11261195B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2020·Granted Mar 1, 2022·0 cites·8 claims
- 3476US10844056B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2019·Granted Nov 24, 2020·0 cites·3 claims
- 3575US10894795B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2020·Granted Jan 19, 2021·0 cites·8 claims
- 3674US9108929B2Quinazoline based EGFR inhibitorsCURIS INC·Filed 2012·Granted Aug 18, 2015·1 cites·20 claims
- 3774US8349856B2Quinazoline based EGFR inhibitorsCURIS INC·Filed 2011·Granted Jan 8, 2013·1 cites·19 claims
- 3873US11135205B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2020·Granted Oct 5, 2021·0 cites·18 claims
- 3973US8975401B2Quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Mar 10, 2015·1 cites·19 claims
- 4072US8691820B2CDK inhibitorsQIAN CHANGGENG·Filed 2011·Granted Apr 8, 2014·2 cites·17 claims
- 4170US8426419B2Tyrosine kinase inhibitors containing a zinc binding moietyCAI XIONG·Filed 2011·Granted Apr 23, 2013·1 cites·15 claims
- 4267US9040556B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2013·Granted May 26, 2015·0 cites·24 claims
- 4367US9024024B2Quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted May 5, 2015·0 cites·5 claims
- 4466US10035797B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2017·Granted Jul 31, 2018·0 cites·8 claims
- 4566US9630965B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2016·Granted Apr 25, 2017·0 cites·4 claims
- 4666US6077846AEpibatidine and derivatives thereof as cholinergic receptor agonists and antagonistsUCB SA·Filed 1994·Granted Jun 20, 2000·18 cites·10 claims
- 4763US11306102B21,3-di-substituted ketene compound and application thereofBEBETTER MED INC·Filed 2018·Granted Apr 19, 2022·1 cites·19 claims
- 4862US9402832B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2015·Granted Aug 2, 2016·0 cites·4 claims
- 4961US9708299B2Hedgehog antagonists having zinc binding moietiesCURIS INC·Filed 2013·Granted Jul 18, 2017·0 cites·10 claims
- 5059US2015018385A1Fused amino pyridines for the treatment of brain tumorsCURIS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Changgeng Qian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →